methotrexate has been researched along with Rheumatism in 185 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (7.03) | 18.7374 |
| 1990's | 35 (18.92) | 18.2507 |
| 2000's | 47 (25.41) | 29.6817 |
| 2010's | 46 (24.86) | 24.3611 |
| 2020's | 44 (23.78) | 2.80 |
| Authors | Studies |
|---|---|
| Asano-Mori, Y; Chiba, S; Hattori, K; Ishiwata, K; Izutsu, K; Kageyama, K; Kaji, D; Kusakabe, M; Makishima, K; Mitsuki, T; Nishida, A; Ota, Y; Sakata-Yanagimoto, M; Suehara, Y; Takagi, S; Taniguchi, S; Taya, Y; Ubara, Y; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yuasa, M | 1 |
| Förger, F; Häfeli, C | 1 |
| Drosos, AA; Pieta, A; Skalkou, A; Venetsanopoulou, AI; Voulgari, PV; Zioga, A | 1 |
| Argyropoulou, OD; Bakasis, AD; Bitzogli, K; Chatzis, LG; Cinoku, II; Fotiadis, DI; Gazi, S; Georgountzos, AI; Goules, AV; Katechis, S; Katsifis, G; Katsimpari, C; Liossis, SN; Mavrommati, M; Moutsopoulos, HM; Papagoras, C; Pezoulas, V; Sfontouris, CI; Skopouli, FN; Stergiou, IE; Tzioufas, AG; Venetsanopoulou, AI; Vlachoyiannopoulos, PG; Voulgari, PV | 1 |
| Albrecht, K; Iking-Konert, C; Krüger, K; Leipe, J; Poddubnyy, D; Scholz, R; Sewerin, P | 1 |
| Benoy, S; Broen, J; den Broeder, AA; Lamers-Karnebeek, F; Opdam, MAA; Traksel, RAM; Van Bijnen, S; Verhoef, LM; Vos, P | 1 |
| Albach, FN; Arumahandi de Silva, AN; Biesen, R; Burmester, GR; Corman, VM; Drosten, C; Frommert, LM; Jeworowski, LM; Klotsche, J; Scholz, V; Schwarz, T; Ten Hagen, A; Zernicke, J | 1 |
| Fischer, N; Haas, JP; Hugle, B | 1 |
| Akashi, K; Arinobu, Y; Ayano, M; Hiura, J; Horiuchi, T; Hotta, T; Irino, K; Kang, D; Kashiwado, Y; Kawano, S; Kimoto, Y; Mitoma, H; Nakano, S; Niiro, H; Ohshima, S; Ono, N; Sawabe, T; Takeuchi, T; Wang, Q | 1 |
| Andreu, JL; Carmona, L; Loza, E; Otón, T; Rosario, MP | 1 |
| Dobashi, H; Inoo, M; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Miyagi, T; Mizusaki, M; Nakashima, S; Nomura, Y; Shimada, H; Sugihara, K; Wakiya, R | 1 |
| Auroux, M; Confavreux, CB; Coste, B; Coury, F; Durieu, I; Laurent, B; Lega, JC; Mainbourg, S; Massy, E; Mercier, A | 1 |
| Colhoun, HM; Hollick, RJ; McAllister, DA; McKeigue, PM; Porter, D; Ralston, SH | 1 |
| Ahmed, S; Benny, J; Cherian, S; Mehta, P; Panthak, A; Paul, A; Shenoy, P | 1 |
| Broyde, A; Elalouf, O; Elias, M; Elkayam, O; Eviatar, T; Feld, J; Freund, T; Furer, V; Gazitt, T; Gertel, S; Haddad, A; Hagin, D; Higazi, N; Kaufman, I; Kharouf, F; Levartovsky, D; Nevo, S; Paran, D; Pel, S; Peleg, H; Polachek, A; Zisman, D | 1 |
| Alcobendas Rueda, R; Calvo, C; Cámara, C; Díaz Almirón, M; Díaz-Delgado, B; Falces-Romero, I; Méndez-Echevarría, A; Miguel Berenguel, L; Millán Longo, C; Muñoz Gómez, C; Ochando, J; Remesal Camba, A; Udaondo, C | 1 |
| Kao, WC; Lee, YH; Liu, CT; Ma, KS | 1 |
| Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N | 1 |
| Bergeal, E; Brigaud, A; Gervais, E; Larid, G | 1 |
| Oberhofer, E | 1 |
| Chen, L; Li, HJ; Lin, SP; Zheng, YQ | 1 |
| Bhartia, M; Curhan, G; Hoffman, V; Meng, R; Paulus, JK; Starzyk, K; Su, Z; Yoshida, K | 1 |
| İlhan, G; Kimyon, G | 1 |
| Ciechomska, M; Kuca-Warnawin, E; Wroński, J | 1 |
| Lyu, H; Solomon, DH; Vanni, KMM | 1 |
| Cai, SCS; Lee, JSS; Tan, LS; Tee, SI | 1 |
| Akikusa, JD; Atsali, E; Kasapcopur, O; Kulcsár, A; Makay, B; Maritsi, D; Moshe, V; Onozo, B; Rigante, D; Rodrigues, M; Salviato Pileggi, G; Smerla, R; Toplak, N; Tróbert-Sipos, D; Uziel, Y; Wulffraat, N | 1 |
| Kvarstein, G; Skirbekk, H; Sørensen, K; Wøien, H | 1 |
| Birru Talabi, M; Clowse, MEB | 1 |
| Furia, FF; Godfrey, E; Mwamanenge, N; Swai, P | 1 |
| Allenbach, Y; Benesova, K; Bingham, CO; Calabrese, LH; Choy, EH; Cope, AP; Finckh, A; Gottenberg, JE; Haanen, JBAG; Jamal, S; Kostine, M; Lambotte, O; Larkin, J; Leipe, J; Marabelle, A; Mariette, X; Radstake, TRDJ; Rusthoven, C; Schaeverbeke, T; Schulze-Koops, H; Thomasen, L; Visser, K; Visser, M | 1 |
| Alvaro-Gracia, JM; Diaz-Torne, C; Gomez-Reino, J; Gonzalez-Gay, MA; Manero, J; Pego-Reigosa, JM; Rúa-Figueroa, Í; Sanchez-Piedra, C | 1 |
| Solomon, DH; Vanni, KMM | 1 |
| Murray, KE; Turk, MA; Veale, DJ | 1 |
| Ito, S | 1 |
| Bender, TTA; Conrad, R; Kravchenko, D; Leyens, J; Mücke, M; Seidel, MF; Sellin, J | 1 |
| Alves, GGB; de Oliveira Rocha, AM; Len, CA; Piotto, DGP; Said, MA; Silva, LSTE; Terreri, MT | 1 |
| Bjornsson, AH; Grondal, G; Gudbjornsson, B; Jonsdottir, T; Kristjansson, M; Love, TJ | 1 |
| Angelow, A; Chenot, JF; Mainz, A; Sierocinski, E; Walker, J | 1 |
| Abhishek, A; Aithal, GP; Card, T; Doherty, M; Grainge, MJ; Mallen, CD; Nakafero, G; Taal, MW; Zhang, W | 1 |
| Baerwald, C; Nguyen, P | 1 |
| Krüger, K | 1 |
| Andreu, JL; Carmona, L; Otón, T | 1 |
| Bermas, BL | 1 |
| Combe, B; Espinoza, F; Le Blay, P | 1 |
| Luu, B; Rodway, GW | 1 |
| Landis, ET; Strowd, LC; Taxter, AJ | 1 |
| Alonso-Arias, R; Alperi, M; Arias-Guillén, M; Camblor, PM; Coto-Segura, P; Enríquez, AI; Escalante, P; García-Alfonso, L; García-Clemente, MM; González Budiño, MT; Martínez-González, S; Morante, I; Palacios Gutiérrez, JJ; Riestra, S; Sánchez Menéndez, MM; Santibáñez, M | 1 |
| Jagdish, RK; Kumar, U; Singh, AD; Suri, TM | 1 |
| Lalani, R; Lyu, H; Solomon, DH; Vanni, K | 1 |
| Jadhav, MP; Jadhav, PM | 1 |
| Barclay, M; Stamp, LK | 1 |
| Chan, ES; Cronstein, BN | 1 |
| Haller, M; Huppertz, HI; Kallinich, T; Minden, K; Niewerth, M; Nimtz-Talaska, A; Sengler, C | 1 |
| Becker, ML; Polk, BI | 1 |
| Beghin, D; Bernard, N; Chambers, C; Clementi, M; Cuppers-Maarschalkerweerd, B; Elefant, E; Eleftheriou, G; Johnson, D; Kao, K; Koren, G; Malm, H; Meister, R; Ornoy, A; Pistelli, A; Pupco, A; Schaefer, C; Shechtman, S; Vial, T; Wacker, E; Weber-Schoendorfer, C; Winterfeld, U | 1 |
| Aguirre, MÁ; Barbero, P; Groisman, B; Koren, G; Martín, MC | 1 |
| Bak Mohammad Zadeh, S; Dastgiri, S; Gader, S; Ghasemi, A; Hajialiloo, M; Khabbazi, A; Kolahi, S; Nazeri, L; Nazeri, M; Poormohammad, A; Sheikholeslami Salmasi, A | 1 |
| Armuzzi, A; Bruzzese, V; Diamanti, AP; Gatta, L; Hassan, C; Laganà, B; Lorenzetti, R; Migliore, A; Ridola, L; Zullo, A | 1 |
| Aglipay, MO; Bechard, MA; Duffy, CM; Jurencak, R; Lemieux, JR; Roth, J; Watanabe Duffy, K | 1 |
| Mager, DR | 1 |
| Bae, DS; Callahan, MJ; Nigrovic, PA; Tuttle, KS; Vargas, SO | 1 |
| Bozzolo, EP; Campochiaro, C; Dagna, L; Della-Torre, E; Nicoletti, R; Sabbadini, MG; Scotti, R; Stone, JH | 1 |
| Corr, M; Kehl, AS; Weisman, MH | 1 |
| Wise, J | 1 |
| Hidaka, M; Hidaka, T; Kawakita, T; Migita, K; Mori, S; Tsuda, H; Ueki, Y; Yoshitama, T | 1 |
| Arfi, S; Blettery, M; Brunier, L; De Bandt, M; Deligny, C; Jean-Baptiste, G; Moinet, F; Polomat, K | 1 |
| Friedman, MA; Winthrop, KL | 1 |
| Arii, K; Fukuda, W; Hagiyama, H; Handa, Y; Hanyu, T; Hayashi, M; Ikeno, Y; Inokuma, S; Katayama, M; Kitaori, T; Koyama, Y; Miyata, M; Mizuki, S; Morita, S; Okada, A; Omoto, A; Sugitani, T; Suzuki, T; Urushidani, Y; Yamasaki, T | 1 |
| Barabareschi, M; Berti, A; Bortolotti, R; Felicetti, M; Guella, A; Morelli, L; Paolazzi, G; Peccatori, S; Vivaldi, P | 1 |
| Kean, IR; Kean, WF | 1 |
| Graydon, SL; Thompson, AE | 1 |
| Bijlsma, JW; Bombardier, C; Boumpas, DT; Canhao, H; Carmona, L; Dougados, M; Edwards, CJ; Hamuryudan, V; Katchamart, W; Kvien, TK; Leeb, BF; Loza, E; Martín-Mola, EM; Martinez-Lopez, JA; Mielants, H; Müller-Ladner, U; Murphy, G; Pereira, IA; Ramos-Remus, C; Salliot, C; Trudeau, J; Valentini, G; van der Heijde, D; Visser, K; Zochling, J; Østergaard, M | 1 |
| Godeau, B; Khellaf, M | 1 |
| Mimori, T | 1 |
| Tanaka, Y | 1 |
| Braun, J; Rau, R | 1 |
| Brousse, N; Dumas-Tesici, A; Fraitag, S; Hamel, D; Kluger, N | 1 |
| Aggarwal, R; Block, JA; Ekochin, LH; Manadan, AM; Sequeira, W | 1 |
| Burmester, GR; Dörner, T; Scherer, HU | 1 |
| de Carvalho, JF; Paupitz, JA | 1 |
| Bijlsma, JW; Bombardier, C; Canhão, H; Devlin, J; Dougados, M; Edwards, CJ; Gossec, L; Hamuryudan, V; Kvien, TK; Leeb, BF; Martín-Mola, EM; Mielants, H; Müller-Ladner, U; Ostergaard, M; Pereira, IA; Ramos-Remus, C; Zochling, J | 1 |
| Hakala, M; Immonen, K; Kautiainen, H; Vasala, M | 1 |
| Bhatia, R; Garg, R; Gleeson, T; Lu, B; Massarotti, E; Rekedal, LR; Solomon, DH | 1 |
| Baslund, B; Faurschou, M; Hansen, A; Hansen, MS; Knudsen, JB; Loft, AG; Madsen, OR; Sørensen, IJ; Østergaard, M | 1 |
| Agarwal, D; Garg, S; Kapoor, S; Malaviya, AN; Sawhney, S; Sharma, A | 1 |
| Briem, S; Lorenz, HM | 1 |
| Fiehn, C | 1 |
| Dupont, LJ; Goeminne, PC; Scheers, H; Verschueren, P | 1 |
| Alvin, GK; Billings, SD; Jamora, MJ; Jurado, SA; Kress, D; Pipkin, CA; Selim, MA | 1 |
| Roberts, RL; Stamp, LK | 1 |
| Akkara Veetil, BM; Bongartz, T | 1 |
| Ikeda, R; Kono, N; Nakashima, K; Sonemoto, E; Ueki, Y; Wada, M | 1 |
| Braun, J; Dybowski, F; Fendler, C; Heldmann, F; Saracbasi, E | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Becker, ML | 1 |
| Girdish, C; Grant, S; Ringold, S; Sullivan, SD; Wallace, CA | 1 |
| McLeod, HL; Siva, C; Yokoyama, WM | 1 |
| Kellner, H; Schiemann, U | 1 |
| Gause, A | 1 |
| Bindi, G; Cimaz, R; Falcini, F; Galluzzi, F; Masi, L; Simonini, G; Stagi, S | 1 |
| Kaarela, K; Klaukka, T | 1 |
| Livermore, P | 1 |
| Cauza, E; Dunky, A | 1 |
| PEZZINI, G | 1 |
| Chira, P; Sandborg, CI | 1 |
| Meissner, T | 1 |
| Abril, A; Cohen, MD | 1 |
| Eberle, M; Jacobowitz, G; Krinsky, G; Mitnick, H; Riles, T; Rockman, C; Rosenzweig, B; Willis, D | 1 |
| Kremer, JM | 1 |
| Hull, RG; Ledingham, JM; Mackay, KR; McCrae, FC; Moitra, RK; Shaban, R; Thomas, AL | 1 |
| Höck, MS; Horneff, G; Michels, H; Niehues, T; Schuchmann, L | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| McLeod, HL; Ranganathan, P | 1 |
| Allam, Y; Fontanges, E; Miossec, P; Nissen, MJ; Trépo, C; Zoulim, F | 1 |
| Harten, P | 1 |
| Maini, RN | 1 |
| Daiou, C; Galanopoulou, V; Katodritou, E; Papadopoulos, N; Pavlitou-Tsiontsi, A; Speletas, M | 1 |
| Athreya, BH; Cuttica, R; Esteves Hilário, MO; Feitosa de Oliveira, SK; Foeldvari, I; Garay, SM; Garcia-Consuegra, J; Harper, J; Higgins, GC; Laxer, R; Lepore, L; Lindsley, C; Machado, C; Martini, G; Moore, TL; Nelson, AM; Peserico, A; Punaro, MG; Silva, CA; Uziel, Y; Van Suijlekom-Smit, LW; Woo, P; Zulian, F | 1 |
| Martin, JJ | 1 |
| Ali, M; Chen, TS; Crues, JV; Troum, OM | 1 |
| Cronstein, BN | 1 |
| Sharp, JT | 1 |
| Burmester, GR; Scherer, HU | 1 |
| Achenie, LE; Belinsky, GS; Blanchard, K; Gupta, RR; Huang, Q; Jayadev, S; Parke, AL; Rosenberg, DW; Rothe, M; Stoll, R; Wu, GY | 1 |
| Villiger, PM; von Esebeck, M; Østensen, M | 1 |
| Gadola, SD; Jüni, P; Matulis, G; Villiger, PM | 1 |
| Glück, T; Müller-Ladner, U | 1 |
| Brouwers, JR; de Jong-van den Berg, LT; van den Berg, PB; van Roon, EN; Vroom, F | 1 |
| Kumagai, S; Nakazawa, T; Sagawa, A; Shane, P; Yamamoto, K | 1 |
| Heiberg, MS; Kaufmann, C; Koldingsnes, W; Kvien, TK; Mikkelsen, K; Mowinckel, P; Rødevand, E | 1 |
| Martini, A; Ruperto, N | 1 |
| Christophidis, N | 1 |
| Willkens, RF | 1 |
| Berkovitch, M; Giesbrecht, E; Klein, J; Koren, G; Laxer, R; Press, J; Silverman, E; Verjee, Z | 1 |
| Dalhoff, K; Gross, WL; Mrowietz, U; Schnabel, A; Stange, EF | 1 |
| Hanasono, MM; Kamel, OW; van de Rijn, M; Warnke, RA | 1 |
| Gross, WL; Iven, H; Koerber, H | 1 |
| Brooks, P; Conaghan, PG | 1 |
| Diamond, T; Laurent, MR; Preston, SJ; Scott, A | 1 |
| Calin, A; Jones, SM | 1 |
| Edmonds, JP; Furst, DE; Paulus, HE; Scott, DL | 1 |
| Bernard, JP; Cottin, V; Massonnet, B; Souquet, PJ; Tébib, J | 1 |
| Bermas, BL; Hill, JA | 1 |
| da Silva, F; Joly, P; Lauret, P; le Loët, X; Mejjad, O; Thomine, E; Thomine, JM; Vittecoq, O | 1 |
| Nasonov, EL | 1 |
| Ramsey-Goldman, R; Schilling, E | 1 |
| Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
| Kamel, OW | 1 |
| Peter, HH | 1 |
| Furst, DE; Hillson, JL | 1 |
| West, SG | 1 |
| Furst, DE | 1 |
| Pettersson, T | 1 |
| Wallace, CA | 1 |
| Bleyer, WA | 1 |
| Carreño Pérez, L; López Longo, FJ; Monteagudo Sáez, I; Montilla Morales, C; Moreno García, AC; Moreno Zazo, M | 1 |
| Kalden, JR; Lorenz, HM | 1 |
| Laxer, RM | 1 |
| Caballero-Uribe, CV | 1 |
| Padovan, M; Trotta, F | 1 |
| Goodman, M | 1 |
| Hollister, JR | 1 |
| Callen, JP | 1 |
| Antoni, CE; Breedveld, FC; Burmester, GR; Crofford, LJ; Furst, DE; Kalden, JR; Kavanaugh, A; Keystone, EC; Smolen, JS | 1 |
| Arthur, V; Homer, D; Jubb, R | 1 |
| Coblyn, JS; Husni, ME; Karlson, EW; Phillips, K | 1 |
| Baggiolini, M; Ceska, M; Dewald, B; Gerber, N; Seitz, M | 1 |
| Jaffe, IA | 1 |
| Clough, JD; Reardon, EV | 1 |
| Bálint, GP; Petrou, P; Rooney, PJ; Szebenyi, B | 1 |
| Alvillar, RE; O'Grady, L; Robbins, D | 1 |
| Grosflam, J; Weinblatt, ME | 1 |
| Breitbart, A; Krastel, H; Pezzutto, A; Schwarz-Eywill, M | 1 |
| Christophidis, N; Cosolo, W; Drummer, OH | 1 |
| Solomon, SD | 1 |
| Clements, PJ; Davis, J | 1 |
| Brooks, PM; O'Callaghan, JW | 1 |
| Dugowson, CE; Gilliland, BC | 1 |
| Sahn, SA | 1 |
| Desmons, F; Huriez, C; Struyve, J | 1 |
| Rothermich, NO | 1 |
| Missmahl, HP | 1 |
| Krampac, I | 1 |
67 review(s) available for methotrexate and Rheumatism
| Article | Year |
|---|---|
[Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].
Topics: Antirheumatic Agents; Breast Feeding; Female; Humans; Methotrexate; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 2021 |
Fibroblastic rheumatism: an uncommon arthritis. A case-based review.
Topics: Arthritis; Female; Fibroblasts; Fibrosis; Humans; Male; Methotrexate; Middle Aged; Rheumatic Diseases; Skin | 2022 |
Use of parenteral methotrexate in rheumatic diseases: A systematic review.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; Humans; Methotrexate; Rheumatic Diseases | 2022 |
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis.
Topics: Abatacept; Adult; Aged; Antirheumatic Agents; Cohort Studies; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Leflunomide; Methotrexate; Observational Studies as Topic; Pandemics; Rheumatic Diseases; Rituximab; SARS-CoV-2; Seroepidemiologic Studies; Serotonin Agents; Spike Glycoprotein, Coronavirus; Vaccination | 2022 |
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic.
Topics: Adult; COVID-19; COVID-19 Vaccines; Humans; Influenza Vaccines; Methotrexate; Pandemics; Rheumatic Diseases; Rheumatology; Vaccination | 2023 |
Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.
Topics: Anemia; Antirheumatic Agents; Arthritis, Rheumatoid; Folic Acid; Humans; Leucovorin; Leukopenia; Methotrexate; Neutropenia; Pancytopenia; Randomized Controlled Trials as Topic; Rheumatic Diseases; Severity of Illness Index; Thrombocytopenia; Vitamin B Complex | 2020 |
Antirheumatic medications in pregnancy and breastfeeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Products; Breast Feeding; Clinical Decision-Making; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Premature Birth; Rheumatic Diseases; Rheumatology | 2020 |
Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Rheumatic Diseases; Virus Activation | 2021 |
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis.
Topics: Humans; Immunosuppressive Agents; Methotrexate; Rare Diseases; Rheumatic Diseases; Rituximab | 2020 |
Lactation and Management of Postpartum Disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Breast Feeding; Contraindications; Cyclophosphamide; Disease Progression; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Lactation; Lupus Erythematosus, Systemic; Methotrexate; Postpartum Period; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2017 |
Does low-dose methotrexate deserve more respect from clinicians?
Topics: Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Methotrexate; Rheumatic Diseases | 2017 |
Low-Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Adult; Aged; Alopecia; Antirheumatic Agents; Double-Blind Method; Female; Folic Acid; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Oral Ulcer; Prevalence; Randomized Controlled Trials as Topic; Rheumatic Diseases; Stomatitis | 2020 |
Therapeutic drug monitoring in rheumatic diseases: utile or futile?
Topics: Allopurinol; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Monitoring; Gout Suppressants; Humans; Methotrexate; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2014 |
Mechanisms of action of methotrexate.
Topics: Animals; Antirheumatic Agents; Humans; Methotrexate; Rheumatic Diseases; Treatment Outcome | 2013 |
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
Topics: Antirheumatic Agents; Azathioprine; Biological Products; Biomarkers; Child; Genome, Human; Genotype; Humans; Methotrexate; Mycophenolic Acid; Pharmacogenetics; Phenotype; Precision Medicine; Rheumatic Diseases | 2013 |
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Drug Therapy, Combination; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Polyethylene Glycols; Psoriasis; Randomized Controlled Trials as Topic; Recurrence; Rheumatic Diseases; Risk Factors; Tuberculosis; Tumor Necrosis Factor-alpha | 2014 |
Methotrexate.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Home Health Nursing; Humans; Long-Term Care; Methotrexate; Neoplasms; Patient Education as Topic; Rheumatic Diseases; Risk Assessment | 2015 |
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Autoimmunity; Bone Morphogenetic Proteins; Cytokines; Fibrocartilage; Humans; Interleukin-22; Interleukin-23; Interleukins; Magnetic Resonance Imaging; Methotrexate; Rheumatic Diseases; Rituximab; Spondylarthropathies; Tendinopathy; Thalidomide; Tumor Necrosis Factor-alpha; Versicans | 2016 |
Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist.
Topics: Abatacept; Antirheumatic Agents; Contraindications; Drug Interactions; Herpes Zoster Vaccine; Humans; Immunocompromised Host; Immunogenicity, Vaccine; Influenza Vaccines; Methotrexate; Piperidines; Pneumococcal Vaccines; Pyrimidines; Pyrroles; Rheumatic Diseases; Rheumatologists; Rituximab; Vaccines; Vaccines, Attenuated; Yellow Fever Vaccine | 2017 |
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature.
Topics: Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Methotrexate; Rheumatic Diseases; RNA, Viral | 2018 |
Clinical pharmacology of gold.
Topics: Auranofin; Gold; Humans; Methotrexate; Rheumatic Diseases | 2008 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
[Recent progress in clinical trials for rheumatic diseases].
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Immunoconjugates; Interleukin-6; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Lupus Erythematosus, Systemic; Methotrexate; Protein-Tyrosine Kinases; Rheumatic Diseases; Rituximab; Signal Transduction; Syk Kinase; Tumor Necrosis Factor-alpha | 2009 |
An update on methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Methotrexate; Pharmacogenetics; Rheumatic Diseases | 2009 |
Patient-tailored therapy in rheumatoid arthritis: an editorial review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers, Pharmacological; Clinical Protocols; Drug Design; Humans; Immunologic Factors; Methotrexate; Physician-Patient Relations; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2010 |
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
Topics: Antirheumatic Agents; Biomarkers, Pharmacological; Dose-Response Relationship, Drug; Folic Acid; Genome-Wide Association Study; Humans; Metabolic Networks and Pathways; Methotrexate; Polyglutamic Acid; Polymorphism, Genetic; Reduced Folate Carrier Protein; Rheumatic Diseases | 2011 |
Perioperative care for patients with rheumatic diseases.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Contraindications; Glucocorticoids; Guidelines as Topic; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Perioperative Care; Perioperative Period; Rheumatic Diseases; Risk Factors; Societies, Medical; Withholding Treatment | 2011 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Pharmacogenomics in pediatric rheumatology.
Topics: Antimetabolites; Antirheumatic Agents; Azathioprine; Biological Products; Child; Humans; Methotrexate; Models, Biological; Mycophenolic Acid; Pharmacogenetics; Precision Medicine; Rheumatic Diseases; Rheumatology | 2012 |
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field.
Topics: Analgesics, Opioid; Antirheumatic Agents; Azathioprine; Drug Design; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Forecasting; Genetics, Population; Humans; Male; Methotrexate; Pharmacogenetics; Rheumatic Diseases; Rheumatology; Risk Assessment; United States | 2002 |
[Gastrointestinal side effects in the therapy of rheumatologic diseases].
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Etanercept; Gastrointestinal Diseases; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Stomach Ulcer; Sulfasalazine; Tumor Necrosis Factor-alpha | 2002 |
[Methotrexate therapy in rheumatologic diseases--an update].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Rheumatic Diseases | 2003 |
Novel therapies in pediatric rheumatic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Child; Genetic Therapy; Humans; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Neoplasm Proteins; Receptors, Tumor Necrosis Factor, Type II; Rheumatic Diseases; Rituximab; Sialoglycoproteins; Stem Cell Transplantation; Tumor Necrosis Factor Decoy Receptors | 2003 |
Rheumatologic manifestations of sarcoidosis.
Topics: Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Peptidyl-Dipeptidase A; Prednisone; Rheumatic Diseases; Sarcoidosis | 2004 |
Toward a better understanding of methotrexate.
Topics: Antirheumatic Agents; Humans; Methotrexate; Rheumatic Diseases | 2004 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Tumor necrosis factor alpha inhibitors and methotrexate: implications for deployed personnel.
Topics: Antirheumatic Agents; Humans; Methotrexate; Military Personnel; Neoplasm Proteins; Receptors, Tumor Necrosis Factor, Type II; Rheumatic Diseases; Tumor Necrosis Factor Decoy Receptors; United States | 2005 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Clinical Trials, Phase II as Topic; Cohort Studies; Collagen Diseases; Drug Therapy, Combination; Etanercept; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunoglobulin G; Infliximab; Methotrexate; Placebos; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Rheumatic Diseases; Rituximab; Spondylarthropathies; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Azathioprine; Biological Products; Cyclophosphamide; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Surgical Wound Infection; Tumor Necrosis Factor-alpha; Wound Healing | 2007 |
Reappraisal of the use of methotrexate in rheumatic disease.
Topics: Absorption; Bone Marrow; Clinical Trials as Topic; Drug Interactions; Humans; Liver; Methotrexate; Myositis; Psoriasis; Rheumatic Diseases; Tissue Distribution | 1983 |
[Methotrexate therapy of inflammatory diseases. Reliable effects and recent developments in rheumatology, pneumology, gastroenterology and dermatology].
Topics: Asthma; Clinical Trials as Topic; Humans; Inflammatory Bowel Diseases; Methotrexate; Psoriasis; Rheumatic Diseases | 1995 |
Immunosuppression-associated lymphoproliferative disorders in rheumatic patients.
Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; Female; Follow-Up Studies; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppression Therapy; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Rheumatic Diseases; Risk; Sjogren's Syndrome; Tumor Virus Infections | 1995 |
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
Topics: Anti-Inflammatory Agents; Antimalarials; Drug Therapy, Combination; Gold; Humans; Methotrexate; Penicillamine; Rheumatic Diseases; Sulfasalazine | 1993 |
Effects of immunosuppressive drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infertility, Female; Mercaptopurine; Methotrexate; Mice; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1995 |
[The use of methotrexate in rheumatology: results and prospects].
Topics: Antirheumatic Agents; Forecasting; Humans; Methotrexate; Rheumatic Diseases; Treatment Outcome | 1996 |
Immunosuppressive drug use during pregnancy.
Topics: Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1997 |
[General principles of immunosuppressive therapy of diseases of rheumatic origin].
Topics: Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Humans; Immunosuppressive Agents; Methotrexate; Rheumatic Diseases | 1997 |
Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design.
Topics: Antirheumatic Agents; Humans; Methotrexate; Rheumatic Diseases; Treatment Outcome | 1997 |
Methotrexate hepatotoxicity.
Topics: Antirheumatic Agents; Biopsy; Chemical and Drug Induced Liver Injury; Drug Monitoring; Guidelines as Topic; Humans; Liver; Methotrexate; Rheumatic Diseases | 1997 |
The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Methotrexate; Rheumatic Diseases; Treatment Outcome | 1997 |
Rheumatic features of sarcoidosis.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis; Humans; Methotrexate; Rheumatic Diseases; Sarcoidosis | 1998 |
The use of methotrexate in childhood rheumatic diseases.
Topics: Antirheumatic Agents; Child, Preschool; Humans; Methotrexate; Rheumatic Diseases | 1998 |
Biologic agents in the treatment of inflammatory rheumatic diseases.
Topics: Animals; Antibodies, Monoclonal; Antirheumatic Agents; CD4 Antigens; Drug Therapy, Combination; Humans; Interleukin-10; Interleukin-4; Methotrexate; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |
[Trends in the treatment of rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclooxygenase Inhibitors; Cyclosporine; Hand; Humans; Immunoglobulins, Intravenous; Knee Joint; Methotrexate; Osteoarthritis; Plasmapheresis; Radiography; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |
Medical treatment of adolescents with rheumatic disease.
Topics: Adolescent; Adolescent Medicine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Pregnancy; Rheumatic Diseases; Sulfasalazine | 1998 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001).
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Contraindications; Controlled Clinical Trials as Topic; Female; Humans; Male; Meta-Analysis as Topic; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2001 |
New approaches to the management of rheumatoid arthritis.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Arthritis, Rheumatoid; CD4 Antigens; Cyclosporine; Drug Therapy, Combination; Humans; Immunotherapy; Magnetic Resonance Imaging; Methotrexate; Photochemotherapy; Rheumatic Diseases; Rheumatology | 1992 |
Rheumatic syndromes caused by antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Fluorides; Humans; Methotrexate; Organogold Compounds; Penicillamine; Rheumatic Diseases; Steroids | 1991 |
Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity.
Topics: Arthritis, Rheumatoid; Humans; Liver; Methotrexate; Rheumatic Diseases | 1991 |
Methotrexate in the rheumatic diseases.
Topics: Humans; Methotrexate; Rheumatic Diseases | 1989 |
Cytotoxic drugs: their clinical application to the rheumatic diseases.
Topics: Arthritis; Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Cell Division; Chemical and Drug Induced Liver Injury; Chlorambucil; Cyclophosphamide; Depression, Chemical; Dermatomyositis; Drug Evaluation; Female; Fertility; Gastrointestinal Diseases; Granulomatosis with Polyangiitis; Humans; Leukopenia; Lupus Erythematosus, Systemic; Male; Methotrexate; Myositis; Neoplasms; Polyarteritis Nodosa; Psoriasis; Pulmonary Fibrosis; Rheumatic Diseases | 1986 |
Disease-modifying agents and immunosuppressive drugs in the elderly.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cyclophosphamide; Gold; Humans; Immunosuppressive Agents; Kinetics; Methotrexate; Penicillamine; Rheumatic Diseases; Sulfasalazine | 1986 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Felty Syndrome; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leukapheresis; Lung Diseases; Lymphoid Tissue; Methotrexate; Penicillamine; Plasmapheresis; Radiotherapy; Rheumatic Diseases; Salicylates; Sjogren's Syndrome; Spinal Diseases; Vasculitis | 1986 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
An updated look at antirheumatic drugs.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Azathioprine; Chloroquine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Indomethacin; Methotrexate; Nitrogen Mustard Compounds; Rheumatic Diseases; Salicylates | 1967 |
[Amyloidosis in chronic rheumatic diseases].
Topics: Adult; Aged; Amyloidosis; Arthritis, Rheumatoid; Biopsy; Chloroquine; Chronic Disease; Collagen Diseases; Felty Syndrome; Female; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Proteinuria; Psoriasis; Rectum; Rheumatic Diseases; Sjogren's Syndrome; Spondylitis, Ankylosing | 1968 |
4 trial(s) available for methotrexate and Rheumatism
| Article | Year |
|---|---|
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Bone Density; Calcaneus; Child; Child, Preschool; Chronic Disease; Dermatomyositis; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Prednisolone; Regression Analysis; Rheumatic Diseases; Ultrasonography | 2003 |
Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritis.
Topics: Antirheumatic Agents; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Metacarpophalangeal Joint; Methotrexate; Patient Compliance; Prognosis; Rheumatic Diseases; Sensitivity and Specificity; Tumor Necrosis Factor-alpha; Wrist | 2006 |
Reappraisal of the use of methotrexate in rheumatic disease.
Topics: Absorption; Bone Marrow; Clinical Trials as Topic; Drug Interactions; Humans; Liver; Methotrexate; Myositis; Psoriasis; Rheumatic Diseases; Tissue Distribution | 1983 |
Experience with etanercept in an academic medical center: are infection rates increased?
Topics: Academic Medical Centers; Antirheumatic Agents; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Infections; Male; Massachusetts; Methotrexate; Middle Aged; Prednisone; Receptors, Tumor Necrosis Factor; Rheumatic Diseases | 2002 |
115 other study(ies) available for methotrexate and Rheumatism
| Article | Year |
|---|---|
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Histone-Lysine N-Methyltransferase; Hodgkin Disease; Humans; Iatrogenic Disease; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Myeloid-Lymphoid Leukemia Protein; Prognosis; Progression-Free Survival; Proportional Hazards Models; Receptors, Tumor Necrosis Factor, Member 14; Retrospective Studies; Rheumatic Diseases; Tacrolimus; Tumor Necrosis Factor alpha-Induced Protein 3 | 2021 |
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
Topics: 2019-nCoV Vaccine mRNA-1273; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; Autoimmune Diseases; BNT162 Vaccine; COVID-19; Female; Greece; Hereditary Autoinflammatory Diseases; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Rheumatic Diseases; Rituximab; SARS-CoV-2; Young Adult | 2021 |
[Perioperative management of treatment of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society of Rheumatology].
Topics: Antirheumatic Agents; Biological Products; Humans; Methotrexate; Practice Guidelines as Topic; Rheumatic Diseases; Rheumatology | 2022 |
Identification of Risk Factors for COVID-19 Hospitalization in Patients With Anti-Rheumatic Drugs: Results From a Multicenter Nested Case Control Study.
Topics: Aged; Antirheumatic Agents; Case-Control Studies; COVID-19; Hospitalization; Humans; Methotrexate; Rheumatic Diseases; Risk Factors | 2022 |
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Topics: Aged; Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Immunogenicity, Vaccine; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; SARS-CoV-2; Vaccination | 2022 |
In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration.
Topics: Arthritis, Rheumatoid; Child; Humans; Methotrexate; Rheumatic Diseases | 2022 |
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.
Topics: Abatacept; Antibody Formation; Calcineurin Inhibitors; Cohort Studies; COVID-19; COVID-19 Vaccines; Cyclophosphamide; Humans; Immunosuppressive Agents; Japan; Methotrexate; Mycophenolic Acid; Prospective Studies; Rheumatic Diseases; Rituximab; SARS-CoV-2; Tumor Necrosis Factor Inhibitors | 2023 |
Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy.
Topics: Antibodies, Viral; BNT162 Vaccine; COVID-19; Humans; Immunogenicity, Vaccine; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Neutralization Tests; Rheumatic Diseases; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; COVID-19; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Prednisolone; Rheumatic Diseases | 2023 |
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.
Topics: Autoimmune Diseases; ChAdOx1 nCoV-19; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; Mycophenolic Acid; Rheumatic Diseases; Sulfasalazine; Vaccines | 2022 |
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study.
Topics: Abatacept; Adult; Antibodies, Viral; Antirheumatic Agents; Autoimmune Diseases; BNT162 Vaccine; COVID-19; Humans; Immunogenicity, Vaccine; Immunoglobulin G; Janus Kinases; Methotrexate; Prospective Studies; Rheumatic Diseases; Rituximab | 2022 |
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases.
Topics: Adolescent; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Interleukin-2; Methotrexate; Rheumatic Diseases; RNA, Messenger; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Viral Vaccines | 2022 |
Long-term safety and efficacy of methotrexate in patients with palindromic rheumatism.
Topics: Arthritis, Rheumatoid; Humans; Methotrexate; Rheumatic Diseases | 2022 |
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
Topics: Adrenal Cortex Hormones; Ambulatory Care Facilities; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Azathioprine; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Rheumatology; Sarcoidosis | 2022 |
Paternity desire during rheumatic diseases under DMARDs: Information of patients and neonatal consequences in a French cohort of 156 patients.
Topics: Antirheumatic Agents; Humans; Infant, Newborn; Methotrexate; Paternity; Rheumatic Diseases; Sulfasalazine | 2023 |
Topics: Arthritis, Rheumatoid; Folic Acid; Humans; Methotrexate; Rheumatic Diseases | 2022 |
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases.
Topics: Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; Hydroxychloroquine; Immunogenicity, Vaccine; Immunoglobulin G; Lupus Erythematosus, Systemic; Methotrexate; Rheumatic Diseases; Rheumatic Fever; Rituximab | 2022 |
More than half of patients with a rheumatic disease or immunologic condition undergoing methotrexate treatment reside in states in which the overturning of Roe v. Wade can jeopardize access to medications with abortifacient potential.
Topics: Abortifacient Agents; Health Services Accessibility; Humans; Immune System Diseases; Methotrexate; Rheumatic Diseases; United States | 2023 |
Is the treatment of inflammatory arthritis different in sickle cell disease?
Topics: Anemia, Sickle Cell; Arthritis, Rheumatoid; Female; Humans; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Tumor Necrosis Factor Inhibitors | 2022 |
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma.
Topics: Antirheumatic Agents; Cyclosporine; Diagnosis, Differential; Female; Fibroblasts; Giant Cells; Hemangioma; Histiocytoma; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Rheumatic Diseases; Skin Diseases; Skin Neoplasms | 2020 |
Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
Topics: Chickenpox Vaccine; Child; Child, Preschool; Data Collection; Female; Humans; Immunization, Secondary; Immunosuppressive Agents; Male; Measles-Mumps-Rubella Vaccine; Methotrexate; Retrospective Studies; Rheumatic Diseases; Vaccines, Attenuated; Vaccines, Combined | 2020 |
Children's fear of needle injections: a qualitative study of training sessions for children with rheumatic diseases before home administration.
Topics: Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Child; Child, Preschool; Etanercept; Fear; Female; Humans; Injections, Subcutaneous; Male; Methotrexate; Needles; Nurse-Patient Relations; Nurses; Pain, Procedural; Parent-Child Relations; Parents; Patient Education as Topic; Qualitative Research; Rheumatic Diseases | 2020 |
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
Topics: Adolescent; Anemia; Antibodies, Antinuclear; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; C-Reactive Protein; Child; Child, Preschool; Computed Tomography Angiography; Cyclophosphamide; Dermatomyositis; Echocardiography; Edema; Exanthema; Female; Fever; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Angiography; Male; Methotrexate; Mixed Connective Tissue Disease; Mucocutaneous Lymph Node Syndrome; Prednisolone; Retrospective Studies; Rheumatic Diseases; Takayasu Arteritis; Tanzania; Tertiary Care Centers | 2020 |
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Topics: Advisory Committees; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthralgia; Arthritis, Psoriatic; Arthritis, Reactive; Autoantibodies; Decision Making, Shared; Deprescriptions; Europe; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Immunoglobulins, Intravenous; Immunologic Factors; Medical Oncology; Methotrexate; Myalgia; Myocarditis; Myositis; Neoplasms; Plasma Exchange; Polymyalgia Rheumatica; Rheumatic Diseases; Rheumatology; Severity of Illness Index; Societies, Medical; Tumor Necrosis Factor Inhibitors | 2021 |
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Pandemics; Pneumonia, Viral; Rheumatic Diseases; Rituximab; SARS-CoV-2; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2020 |
Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials: reply.
Topics: Antirheumatic Agents; Humans; Methotrexate; Rheumatic Diseases | 2020 |
Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.
Topics: Antirheumatic Agents; Humans; Methotrexate; Rheumatic Diseases | 2020 |
Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Cohort Studies; Dermatomyositis; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methotrexate; Retrospective Studies; Rheumatic Diseases; Risk Factors | 2020 |
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.
Topics: Antirheumatic Agents; COVID-19; Hospitalization; Humans; Hypoxia; Iceland; Methotrexate; Prevalence; Rheumatic Diseases; SARS-CoV-2 | 2021 |
[Patient safety in the treatment of rheumatic diseases : Laboratory monitoring in methotrexate treatment].
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Laboratories; Methotrexate; Patient Safety; Retrospective Studies; Rheumatic Diseases | 2021 |
What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Female; Humans; Immunosuppressive Agents; Incidence; Leflunomide; Liver Diseases; Male; Methotrexate; Middle Aged; Renal Insufficiency; Rheumatic Diseases; Thrombocytopenia; United Kingdom; Withholding Treatment | 2021 |
[Rheumatic diseases, inflammation and cardiovascular risk].
Topics: Antirheumatic Agents; Cardiovascular Diseases; Humans; Inflammation; Methotrexate; Rheumatic Diseases; Risk Factors; Tumor Necrosis Factor-alpha | 2021 |
[Does methotrexate influence the efficacy of vaccination against SARS-CoV-2?]
Topics: Antirheumatic Agents; COVID-19; COVID-19 Vaccines; Humans; Methotrexate; Rheumatic Diseases; SARS-CoV-2; Vaccination | 2021 |
Patient's experiences of the barriers and facilitators to Methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Focus Groups; Humans; Methotrexate; Qualitative Research; Rheumatic Diseases | 2022 |
Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD.
Topics: Abatacept; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biological Products; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Neutropenia; Registries; Retrospective Studies; Rheumatic Diseases | 2017 |
Post-Chikungunya Rheumatic Disease in a 13-Year-Old Boy.
Topics: Adolescent; Chikungunya Fever; Chikungunya virus; Enzyme Inhibitors; Glucocorticoids; Humans; Male; Methotrexate; Mycophenolic Acid; Rheumatic Diseases | 2017 |
High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?
Topics: Adult; False Positive Reactions; Female; Humans; Latent Tuberculosis; Male; Methotrexate; Middle Aged; Prospective Studies; Rheumatic Diseases; Tuberculin Test | 2018 |
Unravelling the NERDS syndrome.
Topics: Adrenal Cortex Hormones; Dermatitis; Edema; Eosinophilia; Facial Paralysis; Finger Joint; Humans; Male; Methotrexate; Rheumatic Diseases; Rheumatoid Nodule; Syndrome; Treatment Outcome; Young Adult | 2018 |
[Chinese expert-based consensus for methotrexate in rheumatic diseases].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Consensus; Humans; Methotrexate; Rheumatic Diseases; Rheumatology | 2018 |
Complementary and alternative medicine and conventional medicine: hand in hand.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Complementary Therapies; Ethnicity; Female; Humans; Interviews as Topic; Male; Medicine, Ayurvedic; Methotrexate; Osteoarthritis; Patient Acceptance of Health Care; Rheumatic Diseases; White People | 2013 |
Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases.
Topics: Adjuvants, Immunologic; Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Autoantibodies; Child; Child, Preschool; Databases, Factual; Female; Germany; Health Status; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Methotrexate; Rheumatic Diseases; Rheumatology; Surveys and Questionnaires; Vaccination | 2014 |
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Case-Control Studies; Cohort Studies; Congenital Abnormalities; Dose-Response Relationship, Drug; Female; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies; Rheumatic Diseases; Risk Factors | 2014 |
Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
Topics: Abnormalities, Multiple; Adolescent; Adult; Antirheumatic Agents; Craniofacial Abnormalities; Female; Fetal Diseases; Humans; Maternal-Fetal Exchange; Methotrexate; Pregnancy; Rheumatic Diseases; Young Adult | 2014 |
Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antirheumatic Agents; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clinical Enzyme Tests; Drug Monitoring; Female; Humans; Male; Methotrexate; Middle Aged; Patient Safety; Predictive Value of Tests; Retrospective Studies; Rheumatic Diseases; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2014 |
Procedural pain and patient-reported side effects with weekly injections of subcutaneous methotrexate in children with rheumatic disorders.
Topics: Adolescent; Anorexia; Antirheumatic Agents; Child; Child, Preschool; Cohort Studies; Fatigue; Female; Humans; Incidence; Injections, Subcutaneous; Male; Methotrexate; Nausea; Pain; Pain Measurement; Prospective Studies; Retrospective Studies; Rheumatic Diseases; Vomiting | 2014 |
Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Cartilage Diseases; Etanercept; Extracellular Matrix; Female; Finger Joint; Humans; Immunoglobulin G; Methotrexate; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; T-Lymphocytes; Toe Joint; Treatment Outcome | 2015 |
Methotrexate for maintenance of remission in IgG4-related disease.
Topics: Aged; Antirheumatic Agents; Cost-Benefit Analysis; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Remission Induction; Rheumatic Diseases; Treatment Outcome | 2015 |
Rheumatic diseases should be actively treated in pregnancy, new guidelines say.
Topics: Adalimumab; Antirheumatic Agents; Certolizumab Pegol; Contraindications; Etanercept; Female; Glucocorticoids; Humans; Methotrexate; Practice Guidelines as Topic; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Rheumatic Diseases | 2016 |
Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Female; Folic Acid; Hematologic Diseases; Humans; Hypoalbuminemia; Male; Methotrexate; Middle Aged; Neutropenia; Pancytopenia; Retrospective Studies; Rheumatic Diseases; Risk Factors; Serum Albumin | 2016 |
Brief Report: Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Bursitis; Carpal Tunnel Syndrome; Chikungunya Fever; Chronic Disease; Epidemics; Female; Fibromyalgia; Humans; Low Back Pain; Male; Martinique; Methotrexate; Middle Aged; Osteoarthritis; Rheumatic Diseases; Spondylarthritis; Tendinopathy; Tumor Necrosis Factor-alpha | 2016 |
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Incidence; Japan; Male; Methotrexate; Middle Aged; Prednisolone; Prospective Studies; Rheumatic Diseases; Risk Factors; Time Factors; Virus Activation; Young Adult | 2017 |
Patient-oriented methotrexate information sites on the Internet: a review of completeness, accuracy, format, reliability, credibility, and readability.
Topics: Antirheumatic Agents; Health Education; Humans; Information Dissemination; Information Services; Internet; Methotrexate; Reproducibility of Results; Rheumatic Diseases; Writing | 2009 |
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E
Topics: Abnormalities, Drug-Induced; Administration, Oral; Antirheumatic Agents; Drug Therapy, Combination; Evidence-Based Medicine; Female; Folic Acid; Humans; Long-Term Care; Male; Methotrexate; Preconception Care; Rheumatic Diseases; Risk Factors | 2009 |
[Pneumocystis pneumonia among patients with systemic diseases].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Methotrexate; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisone; Rheumatic Diseases | 2009 |
Fibroblastic rheumatism: fibromatosis rather than non-Langerhans cell histiocytosis.
Topics: Child; Diagnosis, Differential; Fibroblasts; Fibroma; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Rheumatic Diseases; Skin; Skin Neoplasms; Treatment Outcome | 2010 |
Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
Topics: Adult; Aged; Antirheumatic Agents; Antitubercular Agents; Cohort Studies; Female; Humans; Isoniazid; Liver; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Transaminases; Tuberculosis | 2009 |
Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism.
Topics: Adult; Antirheumatic Agents; Arthralgia; Fibroblasts; Fibrosis; Humans; Joints; Male; Methotrexate; Penile Induration; Rheumatic Diseases; Rheumatoid Nodule; Skin; Treatment Outcome | 2012 |
Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.
Topics: Antirheumatic Agents; Humans; Information Dissemination; Methotrexate; Practice Guidelines as Topic; Rheumatic Diseases | 2011 |
More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Antirheumatic Agents; Blood Sedimentation; Creatinine; Female; Finland; Humans; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Methotrexate; Middle Aged; Prevalence; Proteinuria; Rectum; Rheumatic Diseases; Subcutaneous Fat, Abdominal; Young Adult | 2010 |
Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Hydroxychloroquine; Insulin; Linear Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Treatment Outcome | 2010 |
Evidence-based recommendations for treatment with methotrexate in rheumatic disorders.
Topics: Adult; Antirheumatic Agents; Delphi Technique; Denmark; Evidence-Based Medicine; Female; Health Status Indicators; Health Surveys; Humans; Internationality; Male; Methotrexate; Middle Aged; Practice Guidelines as Topic; Rheumatic Diseases; Rheumatology; Surveys and Questionnaires | 2010 |
Low-dose and high-dose methotrexate are two different drugs in practical terms.
Topics: Antineoplastic Agents; Antirheumatic Agents; Dose-Response Relationship, Drug; Humans; Methotrexate; Rheumatic Diseases; Risk Assessment; Terminology as Topic; Treatment Outcome | 2010 |
[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].
Topics: Antirheumatic Agents; Chronic Disease; Germany; Humans; Inflammation; Methotrexate; Off-Label Use; Rheumatic Diseases | 2011 |
[Current status of methotrexate].
Topics: Antirheumatic Agents; Germany; Humans; Methotrexate; Rheumatic Diseases; Rheumatology | 2011 |
Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis.
Topics: Aged; Antirheumatic Agents; Bronchiectasis; Cross-Sectional Studies; Female; Humans; Immunologic Factors; Immunomodulation; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Respiratory Function Tests; Retrospective Studies; Rheumatic Diseases; Treatment Outcome | 2012 |
Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications.
Topics: Adolescent; Antirheumatic Agents; Arthritis; Child; Contracture; Diagnosis, Differential; Fibroblasts; Humans; Immunologic Factors; Interferon-alpha; Male; Methotrexate; Raynaud Disease; Rheumatic Diseases | 2012 |
Practical determination of methotrexate in serum of rheumatic patients by LC-MS/MS.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chromatography, Liquid; Female; Humans; Male; Methotrexate; Middle Aged; Reproducibility of Results; Rheumatic Diseases; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
[Practical problems by implementation of vaccination recommendations].
Topics: Antibody Formation; Antirheumatic Agents; Biological Products; Cooperative Behavior; Female; Germany; Glucocorticoids; Humans; Immunization Programs; Immunization Schedule; Immunosuppressive Agents; Interdisciplinary Communication; Male; Medical Records; Methotrexate; Middle Aged; Patient Admission; Patient Compliance; Rheumatic Diseases | 2012 |
Methotrexate and injectable tumor necrosis factor-α inhibitor adherence and persistence in children with rheumatic diseases.
Topics: Adalimumab; Adolescent; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Child; Child, Preschool; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infant; Injections; Medication Adherence; Methotrexate; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2013 |
Progress in the treatment of rheumatic disease.
Topics: Antibodies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Interleukin 1 Receptor Antagonist Protein; Isoenzymes; Membrane Proteins; Methotrexate; Prostaglandin-Endoperoxide Synthases; Recombinant Proteins; Rheumatic Diseases; Sialoglycoproteins; Tumor Necrosis Factor-alpha | 2003 |
Methotrexate is the leading DMARD in Finland.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Finland; Humans; Hydroxychloroquine; Insurance, Health; Methotrexate; Rheumatic Diseases; Sulfasalazine | 2003 |
Teaching home administration of sub-cutaneous methotrexate.
Topics: Antirheumatic Agents; Attitude to Health; Child; Home Nursing; Humans; Injections, Subcutaneous; Methotrexate; Nursing Evaluation Research; Parents; Patient Education as Topic; Patient-Centered Care; Program Evaluation; Rheumatic Diseases; Safety Management; Self Administration; Surveys and Questionnaires; Teaching | 2003 |
[REMARKS ON THE USE OF SMALL INTERMITTENT DOSES OF AN ANTIFOLIC AGENT AMETHOPTERIN IN PSORIATIC RHEUMATISM AND OF NITROGEN MUSTARD IN CHRONIC PROTOTYPIC RHEUMATISM (C.E.P.)].
Topics: Arthritis; Arthritis, Rheumatoid; Drug Therapy; Folic Acid Antagonists; Humans; Mechlorethamine; Methotrexate; Psoriasis; Rheumatic Diseases | 1965 |
[New strategies against autoaggressive immune system. Is rheumatism to be healable soon?].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroscopy; Cells, Cultured; Chondrocytes; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Infliximab; Lupus Erythematosus, Systemic; Methotrexate; Rheumatic Diseases; Scleroderma, Systemic; Stem Cell Transplantation; Tumor Necrosis Factor-alpha | 2003 |
Periaortitis: gadolinium-enhanced magnetic resonance imaging and response to therapy in four patients.
Topics: Aged; Anti-Inflammatory Agents; Arteriosclerosis; Azathioprine; Contrast Media; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Methotrexate; Middle Aged; Prednisone; Retroperitoneal Fibrosis; Rheumatic Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease.
Topics: Administration, Oral; Antirheumatic Agents; Drug Administration Schedule; Humans; Infusions, Parenteral; Methotrexate; Rheumatic Diseases | 2005 |
Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Austria; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Rheumatic Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Methotrexate and long-term treatment of rheumatic disease: comment on the article by Kremer.
Topics: Antirheumatic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Humans; Methotrexate; Rheumatic Diseases | 2005 |
Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Infectious; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Treatment Outcome | 2005 |
[Reducing toxicity of methotrexate with folic acid].
Topics: Antirheumatic Agents; Clinical Trials as Topic; Drug Combinations; Folic Acid; Folic Acid Antagonists; Hematologic Diseases; Humans; Methotrexate; Rheumatic Diseases; Treatment Outcome | 2005 |
The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Methotrexate; Rheumatic Diseases; Rheumatology; Tumor Necrosis Factor-alpha | 2005 |
Relationship between 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Autoimmune Diseases; Dietary Supplements; Drug Interactions; Female; Folic Acid; Humans; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Retrospective Studies; Rheumatic Diseases | 2005 |
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
Topics: Adolescent; Age of Onset; Autoantibodies; Autoimmune Diseases; Child; Child, Preschool; Environment; Female; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; International Cooperation; Male; Methotrexate; Rheumatic Diseases; Risk Factors; Scleroderma, Localized | 2006 |
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Humans; Methotrexate; Pharmacogenetics; Polymorphism, Genetic; Rheumatic Diseases | 2006 |
Magnetic resonance imaging in rheumatologic practice: low field or standard.
Topics: Antirheumatic Agents; Disease Progression; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Methotrexate; Prognosis; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2006 |
The contribution of methotrexate exposure and host factors on transcriptional variance in human liver.
Topics: Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Cluster Analysis; Complement Activation; Female; Folic Acid Antagonists; Gene Expression Regulation; Humans; Liver; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Molecular Sequence Data; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; Rheumatic Diseases; RNA | 2007 |
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Congenital Abnormalities; Contraception; Contraception Behavior; Female; Health Surveys; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Outcome; Rheumatic Diseases | 2007 |
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
Topics: Adult; Antibodies, Monoclonal; Antigens, Bacterial; BCG Vaccine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunologic Tests; Immunosuppressive Agents; Infliximab; Interferon-gamma; Logistic Models; Male; Methotrexate; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prospective Studies; Rheumatic Diseases; Risk Factors; Tuberculin Test; Tuberculosis; Tumor Necrosis Factor-alpha | 2008 |
Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Topics: Antirheumatic Agents; Azathioprine; Databases, Factual; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Female; Humans; Inflammatory Bowel Diseases; Methotrexate; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Rheumatic Diseases; Risk Factors; Sulfasalazine | 2008 |
[New concept on diagnosis and therapy for rheumatoid and collagen diseases (discussion)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Autoantibodies; Collagen Diseases; Diagnostic Imaging; Drug Therapy, Combination; Exercise Therapy; Glucocorticoids; Humans; Immunosuppressive Agents; Insurance, Health; Japan; Joints; Methotrexate; Rheumatic Diseases; Serologic Tests; United States | 2007 |
The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Longitudinal Studies; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Registries; Rheumatic Diseases; Spondylitis, Ankylosing; Survival Analysis; Tumor Necrosis Factor-alpha | 2008 |
Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
Topics: Antirheumatic Agents; Child; Chronic Disease; Clinical Trials as Topic; Drug Labeling; Humans; International Cooperation; Methotrexate; Pediatrics; Rheumatic Diseases; Rheumatology; Surveys and Questionnaires | 2008 |
Methotrexate.
Topics: Abnormalities, Drug-Induced; Arthritis; Arthritis, Rheumatoid; Drug Interactions; Humans; Infant, Newborn; Methotrexate; Myositis; Neoplasms; Psoriasis; Rheumatic Diseases | 1984 |
Evaluation of therapeutic drug monitoring of methotrexate in saliva of children with rheumatic diseases.
Topics: Adolescent; Child; Child, Preschool; Drug Monitoring; Humans; Methotrexate; Rheumatic Diseases; Saliva | 1995 |
Do steroids influence low dose methotrexate pharmacokinetics?
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Steroids | 1994 |
Methotrexate osteopathy in rheumatic disease.
Topics: Aged; Biopsy; Bone and Bones; Bone Diseases; Female; Humans; Methotrexate; Middle Aged; Osteoblasts; Radiography; Rheumatic Diseases | 1993 |
The monitoring of patients on disease-modifying antirheumatoid drugs.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Methotrexate; Rheumatic Diseases | 1993 |
New classification of antirheumatic drugs. The evolution of a concept.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Protocols; Drug Evaluation; Gold; Humans; Methotrexate; Rheumatic Diseases; Terminology as Topic; World Health Organization | 1993 |
Pulmonary function in patients receiving long-term low-dose methotrexate.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Lung; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Respiratory Function Tests; Rheumatic Diseases; Risk Factors | 1996 |
Preliminary experience with low-dose methotrexate in fibroblastic rheumatism.
Topics: Biopsy; Dose-Response Relationship, Drug; Female; Fibroblasts; Humans; Methotrexate; Middle Aged; Rheumatic Diseases; Skin | 1996 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
Lymphomas during long-term methotrexate therapy.
Topics: Adjuvants, Immunologic; Dermatologic Agents; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma; Methotrexate; Rheumatic Diseases | 1997 |
Methotrexate induced lymphoma?
Topics: Antirheumatic Agents; Carcinogenicity Tests; Folic Acid Antagonists; Humans; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Methotrexate; Mutagenicity Tests; Rheumatic Diseases | 1998 |
[Hypertransaminemia and methotrexate: not always a toxic effect?].
Topics: Adult; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Transaminases | 1998 |
Long-term toxicity of immune suppression in juvenile rheumatic diseases.
Topics: Adolescent; Adrenal Cortex Hormones; Alkylating Agents; Antirheumatic Agents; Child; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Rheumatic Diseases; Time | 1999 |
Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et al.
Topics: Antirheumatic Agents; Colombia; Drug Utilization; Humans; Methotrexate; Patient Selection; Practice Patterns, Physicians'; Rheumatic Diseases; Rheumatology; Surveys and Questionnaires | 1999 |
Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
Topics: Adenosine Deaminase Inhibitors; Antirheumatic Agents; Autoimmune Diseases; Cyclophosphamide; Drug Combinations; Enzyme Inhibitors; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Pentostatin; Purine Nucleosides; Rheumatic Diseases | 2000 |
A study of parenteral use of methotrexate in rheumatic conditions.
Topics: Adult; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Pain Measurement; Patient Education as Topic; Patient Satisfaction; Prospective Studies; Rheumatic Diseases; Sampling Studies; Self Administration; Treatment Outcome | 2002 |
Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate.
Topics: Anti-Inflammatory Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Gold Sodium Thiomalate; Humans; Immunoglobulin M; Interleukin-8; Methotrexate; Monocytes; Rheumatic Diseases; Rheumatoid Factor; Synovial Fluid | 1992 |
Drug therapy in the rheumatic diseases.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Gold; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Osteoarthritis; Penicillamine; Rheumatic Diseases | 1992 |
Coexistent Felty's syndrome and palindromic rheumatism.
Topics: Cell Count; Diagnosis, Differential; Felty Syndrome; Humans; Lymphocytes; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Phenotype; Rheumatic Diseases | 1991 |
[Uveitis: occurrence in rheumatic diseases and immunosuppressive therapy].
Topics: Adult; Diagnosis, Differential; Humans; Immune Tolerance; Immunosuppression Therapy; Methotrexate; Rheumatic Diseases; Uveitis | 1991 |
Comparison of high-performance liquid chromatography and the Abbott fluorescent polarization radioimmunoassay in the measurement of methotrexate.
Topics: Administration, Oral; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Fluorescence Polarization; Half-Life; Humans; Indomethacin; Injections, Intravenous; Methotrexate; Radioimmunoassay; Reagent Kits, Diagnostic; Rheumatic Diseases | 1989 |
[Erythrodermia, pustulal psoriasis, rheumatic state in a ten-year-old child. Successful effect of the combination of antibio-corticotherapy and methotrexate].
Topics: Anti-Bacterial Agents; Child; Dermatitis, Exfoliative; Humans; Male; Methotrexate; Psoriasis; Rheumatic Diseases; Triamcinolone | 1970 |
[Positive and negative effects of cytostatic therapy in rheumatic patients].
Topics: Antineoplastic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Rheumatic Diseases; Triaziquone | 1970 |